<DOC>
	<DOCNO>NCT00420654</DOCNO>
	<brief_summary>Growth hormone treatment use girl Turner syndrome increase final height . The aim study evaluate effect growth hormone treatment body composition heart function adult woman Turner syndrome . The hypothesis fat mass decrease lean body mass increase . There limited documentation effect heart study population .</brief_summary>
	<brief_title>Growth Hormone Treatment Women With Turner Syndrome</brief_title>
	<detailed_description>This study randomise , double-blinded , control clinical trial evaluate effect growth hormone ( GH ) treatment adult woman Turner syndrome . The endpoint change body composition heart function evaluate echocardiography ( ECHO ) positron emission tomography ( PET ) . Phase one : 6 month GH placebo treatment . Phase two : `` open label '' participant treat GH 12 month . At baseline , healthy control examine , receive treatment</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Turner syndrome Age 2040 Symptomatic heart disease Anti hypertensive treatment Untreated thyroid disease Adipositas ( BMI &gt; 35 ) Treatment glucocorticoid Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Turner syndrome</keyword>
	<keyword>growth hormone treatment</keyword>
	<keyword>positron emission tomography</keyword>
	<keyword>heart</keyword>
</DOC>